National Health Investors Dirección
Dirección controles de criterios 4/4
El CEO de National Health Investors' es D. Mendelsohn , nombrado en Aug 2015, tiene una permanencia de 8.83 años. compensación anual total es $2.08M, compuesta por 24% salario y 76% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.12% de las acciones de la empresa, por valor de $3.63M. La antigüedad media del equipo directivo y de la junta directiva es de 6.8 años y 7.6 años, respectivamente.
Información clave
D. Mendelsohn
Chief Executive Officer (CEO)
US$2.1m
Compensación total
| Porcentaje del salario del CEO | 24.0% |
| Permanencia del CEO | 8.8yrs |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | 6.8yrs |
| Promedio de permanencia en la Junta Directiva | 7.6yrs |
Actualizaciones recientes de la dirección
Recent updates
National Health Investors: The Lack Of Upside Seems Obvious To Me Here
May 09National Health: Lots To Love, But Valuation Still On The High Side
Feb 23Catch The Senior Housing Rebound With National Health Investors
Nov 27National Health Investors: 7% Yielding REIT Has Improved On Most Metrics
Nov 13National Health Investors: Enjoy This Solid 7%+ Yield, For Now
Aug 30National Health: What We Got Wrong With This Healthcare REIT
Jun 14National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M
Feb 216%-Yielding National Health Investors: No Pain, No Gain
Feb 06National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot
Sep 10National Health Investors Q2 Earnings Preview
Aug 07National Health Investors: A 5.8% Yield, And Little Else
Jun 29National Health Investors: Poor Price Growth, Steady Yield, Uncertain Future
Apr 14National Health Investors: Why This 7% Yielder Is A Buy On The Drop
Feb 06National Health Management Believes The 6.4% Yield Is Sustainable
Nov 17National Health Investors: Strong Fundamentals, Low Price, Long-Term Investment
Oct 11National Health Investors: Buy 'Em When They're Cheap
Sep 26National Health Investors: The Most Bearish Bull Thesis I Hope To Ever Write
Aug 31National Health: Not Out Of The Woods Yet
Aug 10National Health Investors reaches deferral agreement with Bickford
Jun 17Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$132m |
| Dec 31 2023 | US$2m | US$500k | US$136m |
| Sep 30 2023 | n/a | n/a | US$105m |
| Jun 30 2023 | n/a | n/a | US$110m |
| Mar 31 2023 | n/a | n/a | US$92m |
| Dec 31 2022 | US$3m | US$418k | US$66m |
| Sep 30 2022 | n/a | n/a | US$71m |
| Jun 30 2022 | n/a | n/a | US$68m |
| Mar 31 2022 | n/a | n/a | US$85m |
| Dec 31 2021 | US$3m | US$398k | US$112m |
| Sep 30 2021 | n/a | n/a | US$142m |
| Jun 30 2021 | n/a | n/a | US$154m |
| Mar 31 2021 | n/a | n/a | US$159m |
| Dec 31 2020 | US$2m | US$386k | US$185m |
| Sep 30 2020 | n/a | n/a | US$190m |
| Jun 30 2020 | n/a | n/a | US$190m |
| Mar 31 2020 | n/a | n/a | US$186m |
| Dec 31 2019 | US$2m | US$375k | US$160m |
| Sep 30 2019 | n/a | n/a | US$155m |
| Jun 30 2019 | n/a | n/a | US$154m |
| Mar 31 2019 | n/a | n/a | US$152m |
| Dec 31 2018 | US$2m | US$350k | US$154m |
| Sep 30 2018 | n/a | n/a | US$155m |
| Jun 30 2018 | n/a | n/a | US$153m |
| Mar 31 2018 | n/a | n/a | US$154m |
| Dec 31 2017 | US$2m | US$340k | US$159m |
Compensación vs. Mercado: La compensación total de D.($USD2.08M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD6.83M).
Compensación vs. Ingresos: La compensación de D. ha sido consistente con los resultados de la empresa en el último año.
CEO
D. Mendelsohn (62 yo)
8.8yrs
Permanencia
US$2,084,567
Compensación
Mr. D. Eric Mendelsohn has been a Director at National Health Investors, Inc since February 17, 2021. Mr. Mendelsohn serves as the Chief Executive Officer and President at National Health Investors Inc. si...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 8.8yrs | US$2.08m | 0.12% $ 3.7m | |
| Executive VP of Finance | 8.3yrs | US$1.30m | 0.042% $ 1.2m | |
| Executive VP & Chief Investment Officer | 7.3yrs | US$1.19m | 0.092% $ 2.7m | |
| Senior VP & Chief Accounting Officer | 4.1yrs | US$1.02m | 0.016% $ 473.0k | |
| Senior VP & Chief Transaction Officer | 1.3yrs | US$1.05m | 0.12% $ 3.5m | |
| Director of Investor Relations | 4.8yrs | sin datos | sin datos | |
| Director of Corporate Compliance & Human Resources | 9.4yrs | sin datos | sin datos | |
| Senior Vice President of Investments | 6.8yrs | sin datos | sin datos | |
| Corporate Secretary | no data | sin datos | sin datos | |
| Real Estate Transaction Manager | 4.8yrs | sin datos | sin datos |
6.8yrs
Permanencia media
52yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de NHI es experimentado (6.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 3.3yrs | US$2.08m | 0.12% $ 3.7m | |
| Independent Chairman of the Board | 33.4yrs | US$175.86k | 1.97% $ 57.7m | |
| Independent Director | 4.1yrs | US$175.86k | 1.27% $ 37.2m | |
| Independent Director | 4.1yrs | US$175.86k | 0.25% $ 7.4m | |
| Independent Director | 23.3yrs | US$190.86k | 0.050% $ 1.5m | |
| Independent Director | 33.4yrs | US$180.86k | 0.24% $ 7.1m | |
| Independent Director | 2yrs | US$175.86k | 0% $ 0 | |
| Independent Director | 11.2yrs | US$180.86k | 0.036% $ 1.0m |
7.6yrs
Permanencia media
74.5yo
Promedio de edad
Junta con experiencia: La junta directiva de NHI se considera experimentada (7.6 años de antigüedad promedio).